Evidence map›Paper›PMID 28938890›Full record

ArticleMicrobial cell factories2017

Systematic pathway engineering of Corynebacterium glutamicum S9114 for L-ornithine production.

Bin Zhang, Miao Yu, Ying Zhou, Yixue Li, Bang-Ce Ye

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Enhanced l-serine synthesis inSynthetic and systems biotechnology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Production of l-glutamate family amino acids inSynthetic and systems biotechnology · 2021
    Review
  8. Development of a DNA double-strand break-free base editing tool inMetabolic engineering communications · 2020
    Article
  9. Article
  10. Metabolic and evolutionary responses ofBiotechnology for biofuels · 2020
    Article
  11. Recent Advances of L-ornithine Biosynthesis in Metabolically EngineeredFrontiers in bioengineering and biotechnology · 2019
    Review
  12. EngineeringBiotechnology for biofuels · 2019
    Article
  13. Article
  14. Article
  15. Pathway engineering in3 Biotech · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Bin ZhangLaboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China.
Miao YuLaboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China.
Ying ZhouLaboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China.
Yixue LiKey Laboratory of Systems Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Bang-Ce YeLaboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China. bcye@ecust.edu.cn.
East China University of Science and Technology · CNChinese Academy of Sciences · CN

Funding

Tailored Mobile Text Messaging to Reduce Problem DrinkingR34AA021502 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MUENCH, FREDERICK JOHN · 2012 to 2014
$675k
NIAAA NIH HHS R34 AA021502
6 · The paper itself

Abstract

backgroundL-Ornithine is a non-protein amino acid with extensive applications in medicine and the food industry. Currently, L-ornithine production is based on microbial fermentation, and few microbes are used for producing L-ornithine owing to unsatisfactory production titer.

resultsIn this study, Corynebacterium glutamicum S9114, a high glutamate-producing strain, was developed for L-ornithine production by pathway engineering. First, argF was deleted to block L-ornithine to citrulline conversion. To improve L-ornithine production, ncgl1221 encoding glutamate transporter, argR encoding arginine repressor, and putP encoding proline transporter were disrupted. This base strain was further engineered by attenuating oxoglutarate dehydrogenase to increase L-ornithine production. Plasmid-based overexpression of argCJBD operon and lysine/arginine transport protein LysE was tested to strengthen L-ornithine synthesis and transportation. This resulted in efficient L-ornithine production at a titer of 18.4 g/L.

conclusionThese results demonstrate the potential of Corynebacterium glutamicum S9114 for efficient L-ornithine production and provide new targets for strain development.

Indexed as

Amino Acid Transport SystemsBacterial ProteinsCorynebacterium glutamicumFermentationGlutamic AcidMetabolic EngineeringOperonOrnithinePlasmidsAmino Acid Transport SystemsBacterial ProteinsGlutamic AcidOrnithineCorynebacterium glutamicumL-Ornithine productionMetabolic engineering

Identifiers

PMID28938890
PMCPMC5610420
OpenAlexW2758707893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.